E Fund Management Co., Ltd. Cytokinetics Inc Transaction History

E Fund Management Co., Ltd.

$2.06 Billion
Q2 2025

A detailed history of E Fund Management Co., Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 18,919 shares of CYTK stock, worth $1.14 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

18,919

Previous 13,783 37.26%

Holding current value

$1.14 Million

Previous $553,000 13.02%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$29.84 - $42.92 $153,258 - $220,437	5,136 Added 37.26%	18,919 $625,000
Q1 2025 May 12, 2025	BUY	$40.19 - $51.12 $81,947 - $104,233	2,039 Added 17.36%	13,783 $553,000
Q4 2024 Feb 06, 2025	SELL	$46.36 - $58.62 $92,395 - $116,829	-1,993 Reduced 14.51%	11,744 $552,000
Q3 2024 Nov 12, 2024	SELL	$51.22 - $60.16 $112,171 - $131,750	-2,190 Reduced 13.75%	13,737 $725,000
Q2 2024 Aug 12, 2024	BUY	$47.86 - $75.05 $446,820 - $700,666	9,336 Added 141.65%	15,927 $862,000
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $477,742 - $809,801	-7,494 Reduced 53.21%	6,591 $462,000
Q4 2023 Feb 06, 2024	BUY	$26.88 - $83.49 $37,739 - $117,219	1,404 Added 11.07%	14,085 $1.18 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $18,235 - $22,661	619 Added 5.13%	12,681 $374,000
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $39,600 - $49,470	1,214 Added 11.19%	12,062 $393,000
Q1 2023 May 11, 2023	SELL	$33.36 - $45.71 $31,958 - $43,790	-958 Reduced 8.11%	10,848 $382,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $109,742 - $156,805	3,068 Added 35.11%	11,806 $541,000
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $90,491 - $128,012	-2,348 Reduced 21.18%	8,738 $423,000
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $133,412 - $192,353	3,932 Added 54.96%	11,086 $436,000
Q1 2022 May 12, 2022	BUY	$29.74 - $46.0 $69,889 - $108,100	2,350 Added 48.92%	7,154 $263,000
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $35,586 - $48,049	-1,036 Reduced 17.74%	4,804 $219,000
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $4,375 - $8,434	-236 Reduced 3.88%	5,840 $209,000
Q1 2021 May 12, 2021	BUY	$18.57 - $25.68 $112,831 - $156,031	6,076 New	6,076 $141,000

Others Institutions Holding CYTK

# of Institutions

371

Shares Held

129M

Call Options Held

3.62M

Put Options Held

1.14M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.66B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Cytokinetics Inc Transaction History